USANA Health Sciences Inc (USNA) stock
USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.57+0.03 (+0.22%)
Close on Nov 17, 2026Market cap $250.73MP/E –Yield –
USANA Health Sciences operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
USANA Health Sciences's operating cash flow for the twelve months ending Jul 4, 2026 was $27.73M, down 56.0% year over year. For fiscal 2025 it was $22.35M, down 63.4% from the year before. Over ten years it grew -14.8% a year on average. The highest annual figure on record is $160.40M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $22.35M | -63.4% |
| FY2024 | Dec 28, 2024 | $60.99M | -13.7% |
| FY2023 | Dec 30, 2023 | $70.64M | -32.0% |
| FY2022 | Dec 31, 2022 | $103.90M | -14.3% |
| FY2021 | Jan 1, 2022 | $121.23M | -24.4% |
| FY2020 | Jan 2, 2021 | $160.40M | +26.6% |
| FY2019 | Dec 28, 2019 | $126.73M | -16.7% |
| FY2018 | Dec 29, 2018 | $152.12M | +22.9% |
| FY2017 | Dec 30, 2017 | $123.77M | -9.6% |
| FY2016 | Dec 31, 2016 | $136.89M | +22.8% |
| FY2015 | Jan 2, 2016 | $111.47M | +6.0% |
| FY2014 | Jan 3, 2015 | $105.19M | +6.4% |
| FY2013 | Dec 28, 2013 | $98.89M | +6.6% |
| FY2012 | Dec 29, 2012 | $92.81M | +32.4% |
| FY2011 | Dec 31, 2011 | $70.11M | +6.1% |
| FY2010 | Jan 1, 2011 | $66.11M | +103.6% |
| FY2009 | Jan 2, 2010 | $32.47M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jul 4, 2026 | $23.32M | +90.9% |
| Q1 FY2026 | Apr 4, 2026 | $9.76M | -37.0% |
| Q4 FY2025 | Jan 3, 2026 | -$3.39M | -158.6% |
| Q3 FY2025 | Sep 27, 2025 | -$1.96M | -106.6% |
| Q2 FY2025 | Jun 28, 2025 | $12.22M | +52.9% |
| Q1 FY2025 | Mar 29, 2025 | $15.48M | -12.4% |
| Q4 FY2024 | Dec 28, 2024 | $5.79M | -77.8% |
| Q3 FY2024 | Sep 28, 2024 | $29.53M | +32.8% |
| Q2 FY2024 | Jun 29, 2024 | $7.99M | -16.3% |
| Q1 FY2024 | Mar 30, 2024 | $17.68M | +37.8% |
| Q4 FY2023 | Dec 30, 2023 | $26.02M | -35.7% |
| Q3 FY2023 | Sep 30, 2023 | $22.23M | -23.7% |
| Q2 FY2023 | Jul 1, 2023 | $9.55M | -34.6% |
| Q1 FY2023 | Apr 1, 2023 | $12.83M | -34.9% |
| Q4 FY2022 | Dec 31, 2022 | $40.46M | +62.4% |
| Q3 FY2022 | Oct 1, 2022 | $29.13M | -22.3% |
| Q2 FY2022 | Jul 2, 2022 | $14.61M | -62.7% |
| Q1 FY2022 | Apr 2, 2022 | $19.70M | +0.2% |
| Q4 FY2021 | Jan 1, 2022 | $24.92M | -48.0% |
| Q3 FY2021 | Oct 2, 2021 | $37.49M | -23.6% |
| Q2 FY2021 | Jul 3, 2021 | $39.16M | +20.0% |
| Q1 FY2021 | Apr 3, 2021 | $19.66M | -36.1% |
| Q4 FY2020 | Jan 2, 2021 | $47.92M | -14.0% |
| Q3 FY2020 | Sep 26, 2020 | $49.06M | -2.5% |
| Q2 FY2020 | Jun 27, 2020 | $32.64M | +115.3% |
| Q1 FY2020 | Mar 28, 2020 | $30.79M | +457.6% |
| Q4 FY2019 | Dec 28, 2019 | $55.74M | +37.9% |
| Q3 FY2019 | Sep 28, 2019 | $50.31M | -7.7% |
| Q2 FY2019 | Jun 29, 2019 | $15.16M | -59.8% |
| Q1 FY2019 | Mar 30, 2019 | $5.52M | -71.7% |
| Q4 FY2018 | Dec 29, 2018 | $40.43M | -26.7% |
| Q3 FY2018 | Sep 29, 2018 | $54.50M | +318.0% |
| Q2 FY2018 | Jun 30, 2018 | $37.68M | -29.8% |
| Q1 FY2018 | Mar 31, 2018 | $19.52M | +926.7% |
| Q4 FY2017 | Dec 30, 2017 | $55.13M | -0.0% |
| Q3 FY2017 | Sep 30, 2017 | $13.04M | -61.4% |
| Q2 FY2017 | Jul 1, 2017 | $53.70M | – |
| Q1 FY2017 | Apr 1, 2017 | $1.90M | – |
| Q4 FY2016 | Dec 31, 2016 | $55.15M | – |
| Q3 FY2016 | Oct 1, 2016 | $33.76M | – |
See a number that looks wrong?